HROW
HROW
NASDAQ · Pharmaceuticals

Harrow Inc

$26.61
+0.57 (+2.19%)
As of Nov 7, 1:44 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -7.4% upside
Low Target $15.17
Average Target $24.64
High Target $37.47
Current Price $26.61
Current
$26.61
Target
$24.64
$15.17 $24.64 avg $37.47
Scenario Analysis
Bear Case
$15.17
-43.0%
Low target
Base Case
$24.64
-7.4%
Avg target
Bull Case
$37.47
+40.8%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$54.85
-51.5% from high
52-Week Low
$26.46
+0.6% from low
Target vs 52W High
$24.64
-55.1% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $0.23
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%